
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Pharmaceutical executives should study their own scientists. They construct clever tools to explore convoluted phenomena. They are the true friends of complexity.
over 25 years ago
Policy: Task Mastersover 25 years ago
Pharmacia's Carrie Cox: HBA Woman of the Yearover 25 years ago
Under Federal Fireover 25 years ago
Task Force: Enter the Fixersover 25 years ago
The Next Y2Kover 25 years ago
Political Science





